Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1975-10-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0018-5043
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
364-5
|
pubmed:dateRevised |
2009-2-19
|
pubmed:meshHeading |
pubmed-meshheading:1150140-Estrogens,
pubmed-meshheading:1150140-Female,
pubmed-meshheading:1150140-Humans,
pubmed-meshheading:1150140-Luteal Phase,
pubmed-meshheading:1150140-Progesterone,
pubmed-meshheading:1150140-Radioimmunoassay,
pubmed-meshheading:1150140-Radioligand Assay,
pubmed-meshheading:1150140-Spironolactone
|
pubmed:year |
1975
|
pubmed:articleTitle |
Interference by spironolactone of radioassays for progesterone and estrogen.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|